第 1 到 26 筆結果,共 26 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2019 | Mouse Models for Immunotherapy in Hepatocellular Carcinoma | OU, DA-LIANG; Lin, Li; Chen, Chia-Wei; DA-LIANG OU | Cancers | 21 | 20 | |
2 | 2019 | Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma | DA-LIANG OU ; Lin, Yu-Yang; CHIA-LANG HSU ; Lin, Yin-Yao; Chen, Chia-Wei; Yu, Jhang-Sian; SHI-CHUEN MIAW ; PING-NING HSU ; ANN-LII CHENG ; CHIUN HSU | Liver cancer | 24 | 21 | |
3 | 2019 | Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations-Possible Therapeutic Efficacy of Cabozantinib | Ko, Ya-Chen; CHUNG-YI HU ; Liu, Zheng-Hau; HWEI-FANG TIEN ; DA-LIANG OU ; Chien, Hsiung-Fei; LIANG-IN LIN | International journal of molecular sciences | 6 | 5 | |
4 | 2019 | TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma | Lai, Hui-Huang; Li, Chih-Wei; Hong, Chih-Chen; Sun, Hung-Yu; Chiu, Ching-Feng; DA-LIANG OU ; Chen, Pai-Sheng | Molecular oncology | 23 | 22 | |
5 | 2018 | Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy | Lin Y.-Y.; CHING-TING TAN ; Chen C.-W.; DA-LIANG OU ; ANN-LII CHENG ; CHIUN HSU | Seminars in Liver Disease | 62 | 53 | |
6 | 2017 | Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy | YU-YUN SHAO ; BANG-BIN CHEN ; DA-LIANG OU ; ZHONG-ZHE LIN ; CHIH-HUNG HSU ; Wang, M. J.; ANN-LII CHENG ; CHIUN HSU | Alimentary Pharmacology and Therapeutics | 10 | 8 | |
7 | 2017 | Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy | Lin Y.-Z.; DA-LIANG OU ; Chang H.-Y.; Lin W.-Y.; CHIUN HSU ; Chang P.-L. | Chemical Science | 14 | 13 | |
8 | 2016 | Cabozantinib is selectively cytotoxic in acute myeloid leukemia cells with FLT3-internal tandem duplication (FLT3-ITD) | Lu J.-W; Wang A.-N; Liao H.-A; Chen, Chien-Yuan ; HSIN-AN HOU ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Cancer Letters | 25 | 26 | |
9 | 2016 | Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression | CHIUN HSU ; LIANG-IN LIN ; Cheng, Yu-Che; Feng, Zi-Rui; YU-YUN SHAO ; ANN-LII CHENG ; DA-LIANG OU | Clinical Cancer Research | 43 | 41 | |
10 | 2015 | Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma | DA-LIANG OU ; Shyue S.-K.; LIANG-IN LIN ; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; CHIUN HSU ; ANN-LII CHENG | Oncotarget | 12 | 9 | |
11 | 2015 | Zebrafish as a disease model for studying human hepatocellular carcinoma | Lu J.-W.; Ho Y.-J.; Yang Y.-J.; Liao H.-A.; Ciou S.-C.; LIANG-IN LIN ; DA-LIANG OU | World Journal of Gastroenterology | 49 | 38 | |
12 | 2015 | MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine | Lu J.-W.; Lin Y.-M.; Lai Y.-L.; Chen, Chien-Yuan ; CHUNG-YI HU ; HWEI-FANG TIEN ; DA-LIANG OU ; LIANG-IN LIN | Medical Oncology | 20 | 19 | |
13 | 2014 | H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis | Wu P.-C.; Lu J.-W.; Yang J.-Y.; Lin I.-H.; DA-LIANG OU ; Lin Y.-H.; Chou K.-H.; Huang W.-F.; Wang W.-P.; Huang Y.-L.; CHIUN HSU ; LIANG-IN LIN ; Lin Y.-M.; James Shen C.-K.; Tzeng T.-Y. | Cancer Research | 54 | 53 | |
14 | 2014 | Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: The role of survivin | DA-LIANG OU ; Lee B.-S.; LIANG-IN LIN ; Liou J.-Y.; Liao S.-C.; CHIUN HSU ; ANN-LII CHENG | Molecular Cancer | 41 | 33 | |
15 | 2014 | Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma | DA-LIANG OU ; Chang C.-J.; YUNG-MING JENG ; Lin Y.-J.; ZHONG-ZHE LIN ; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; CHIUN HSU ; ANN-LII CHENG | Journal of Gastroenterology and Hepatology (Australia) | 11 | 13 | |
16 | 2013 | Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma | Ying-Chun Shen ; DA-LIANG OU ; CHIUN HSU ; Lin K.-L.; Chang C.-Y.; CHING-YU LIN ; Liu S.-H.; ANN-LII CHENG | British Journal of Cancer | 155 | 146 | |
17 | 2013 | Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway | DA-LIANG OU ; Lee B.-S.; Chang Y.-C.; LIANG-IN LIN ; Liou J.-Y.; CHIUN HSU ; ANN-LII CHENG | PLoS ONE | 10 | 11 | |
18 | 2012 | Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence | Yang T.-H.; DA-LIANG OU ; CHIUN HSU ; Huang S.-H.; Chang P.-L. | Electrophoresis | 17 | 17 | |
19 | 2012 | KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells | Lin Y.-L.; JAU-YU LIAU ; SHAN-CHI YU ; DA-LIANG OU ; LIANG-IN LIN ; LI-HUI TSENG ; YIH-LEONG CHANG ; KUN-HUEI YEH ; ANN-LII CHENG | PLoS ONE | 44 | 35 | |
20 | 2011 | IκB kinases increase Myc protein stability and enhance progression of breast cancer cells | Yeh P.-Y.; YEN-SHEN LU ; DA-LIANG OU ; ANN-LII CHENG | Molecular Cancer | 24 | 23 | |
21 | 2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; HSIN-AN HOU ; WEN-CHIEN CHOU ; DA-LIANG OU ; SUNG-LIANG YU ; HWEI-FANG TIEN ; LIANG-IN LIN | Leukemia | 39 | 37 | |
22 | 2010 | Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells | DA-LIANG OU ; Ying-Chun Shen ; SUNG-LIANG YU ; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; LIANG-IN LIN ; CHIUN HSU ; ANN-LII CHENG | Cancer Research | 70 | 69 | |
23 | 2009 | Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma | DA-LIANG OU ; Ying-Chun Shen ; JA-DER LIANG ; Liou J.-Y.; SUNG-LIANG YU ; Fan H.-H.; Wang D.-S.; YEN-SHEN LU ; CHIUN HSU ; ANN-LII CHENG | Clinical Cancer Research | 32 | 34 | |
24 | 2008 | Role of twist in head and neck carcinoma with lymph node metastasis | DA-LIANG OU ; Chien H.-F.; Chen C.-L.; Lin T.-C.; LIANG-IN LIN | Anticancer Research | 55 | 51 | |
25 | 2006 | Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis | Chen C.-L; DA-LIANG OU | Human Pathology | 20 | 20 | |
26 | 2006 | Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy | DA-LIANG OU ; Chen C.-L.; Lin S.B.; CHIH-HUNG HSU ; LIANG-IN LIN | Journal of Pathology | 61 | 52 |